DrugPatentWatch Database Preview

LUZU Drug Profile

« Back to Dashboard

When do Luzu patents expire, and when can generic versions of Luzu launch?

Luzu is a drug marketed by Medicis and is included in one NDA. There are five patents protecting this drug.

This drug has sixty-four patent family members in twenty-five countries.

The generic ingredient in LUZU is luliconazole. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the luliconazole profile page.

Summary for LUZU

International Patents:	64
US Patents:	5
Applicants:	1
NDAs:	1
Suppliers / Packagers:	2
Bulk Api Vendors:	41
Patent Applications:	23
Drug Prices:	Drug price information for LUZU
DailyMed Link:	LUZU at DailyMed

Generic Entry Opportunity Date for LUZU

NDA:

204153

Dosage:

CREAM;TOPICAL

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for LUZU

Drug Class	Azole Antifungal
Mechanism of Action	Cytochrome P450 2C19 Inhibitors

Synonyms for LUZU

(-)-(E)-((4R)-4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene)(1H-imidazol-1-yl)acetonitrile

(2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-yl-acetonitrile

(2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrile

(R,E)-2-(4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene)-2-(1H-imidazol-1-yl)acetonitrile

164L198

187164-19-8

1H-Imidazole-1-acetonitrile, alpha-((4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene)-, (alphaE)-

2-[(2E,4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-(1H-imidazol-1-yl)acetonitrile

4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene-1-imidazolylacetonitrile

AC1MHEOF

AKOS015897320

AM84645

AN-15036

BCP9000863

C13478

CAS-187164-19-8

CHEBI:34825

CHEMBL2105689

CS-0587

D01980

D0U4XJ

DB08933

DSSTox_CID_28533

DSSTox_GSID_48607

DSSTox_RID_82805

DTXSID3048607

GTPL7366

HE064141

HE320898

HY-14283

Imidazole antimycotic

JA-004

JA-005

Lulicon

Lulicon (TN)

Lulicon|||NND 502

Luliconazole

Luliconazole (JAN/USAN/INN)

Luliconazole [USAN:INN]

Luliconazole, >=98% (HPLC)

Lulifin

Luzu (TN)

MFCD00953915

MolPort-035-395-835

NCGC00182704-01

NCGC00182704-02

NCGC00182704-03

NND 502

NND-502

NND502

PR-2699

RE91AN4S8G

s4258

SCHEMBL342362

SR-01000945039

SR-01000945039-1

Tox21_112942

Tox21_112974

Tox21_112974_1

UNII-5JA16R08FJ component YTAOBBFIOAEMLL-REQDGWNSSA-N

UNII-RE91AN4S8G

W-5249

ZINC3929486

US Patents and Regulatory Information for LUZU

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Medicis	LUZU	luliconazole	CREAM;TOPICAL	204153-001	Nov 14, 2013		RX	Yes	Yes			Y	Y
Medicis	LUZU	luliconazole	CREAM;TOPICAL	204153-001	Nov 14, 2013		RX	Yes	Yes
Medicis	LUZU	luliconazole	CREAM;TOPICAL	204153-001	Nov 14, 2013		RX	Yes	Yes				Y

International Patents for LUZU

Country	Document Number	Estimated Expiration
Japan	2015027984
Japan	5699234
India	2929DEN2015